HRMY (STOCKS)
Harmony Biosciences Holdings, Inc. Common Stock
$38.120000
-0.380000 (-0.99%)
Prev close: $38.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Jeffrey M. Dayno, MD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,214.40M
- Employees
- 268
- P/E (TTM)
- 12.35
- P/B (TTM)
- 2.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.28 | $1.04 | +0.2419 | +23.30% |
|
Mar 2026 (Q1)
|
$0.55 | $0.71 | -0.1579 | -22.31% |
|
Dec 2025 (Q4)
|
$0.38 | $0.91 | -0.5344 | -58.44% |
|
Sep 2025 (Q3)
|
$0.87 | $0.86 | +0.0139 | +1.62% |
Financial Statements
| Revenues | $959.90M |
| Benefits Costs and Expenses | $718.70M |
| Cost Of Revenue | $235.91M |
| Costs And Expenses | $718.70M |
| Gross Profit | $723.99M |
| Operating Expenses | $493.34M |
| Research and Development | $220.87M |
| Other Operating Expenses | $272.47M |
| Operating Income/Loss | $230.65M |
| Income/Loss From Continuing Operations After Tax | $181.27M |
| Income/Loss From Continuing Operations Before Tax | $241.20M |
| Income Tax Expense/Benefit | $59.93M |
| Net Income/Loss | $181.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $181.27M |
| Net Income/Loss Available To Common Stockholders, Basic | $181.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.14 |
| Diluted Earnings Per Share | $3.10 |
| Basic Average Shares | 115,264,663 |
| Diluted Average Shares | 117,293,623 |
| Assets | $1.37B |
| Current Assets | $814.33M |
| Inventory | $6.36M |
| Prepaid Expenses | $19.31M |
| Other Current Assets | $788.66M |
| Noncurrent Assets | $558.75M |
| Intangible Assets | $77.50M |
| Other Non-current Assets | $481.25M |
| Liabilities | $373.84M |
| Current Liabilities | $234.07M |
| Accounts Payable | $21.68M |
| Wages | $12.09M |
| Other Current Liabilities | $200.30M |
| Noncurrent Liabilities | $139.77M |
| Long-term Debt | $153.96M |
| Equity | $999.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $999.24M |
| Liabilities And Equity | $1.37B |
| Net Cash Flow From Operating Activities | $355.08M |
| Net Cash Flow From Operating Activities, Continuing | $355.08M |
| Net Cash Flow From Investing Activities | -$337.57M |
| Net Cash Flow From Investing Activities, Continuing | -$337.57M |
| Net Cash Flow From Financing Activities | -$13.79M |
| Net Cash Flow From Financing Activities, Continuing | -$13.79M |
| Net Cash Flow | $3.72M |
| Net Cash Flow, Continuing | $3.72M |
| Comprehensive Income/Loss | $180.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $180.30M |
| Other Comprehensive Income/Loss | $49.90M |
| Other Comprehensive Income/Loss Attributable To Parent | -$966.00K |